Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children

Kidney International

Volumn 75, Issue 3, 2009, Pages 312-316

  Santiago, Maria José ^a   López Herce, Jesús ^a   Urbano, Javier ^a   Bellón, Jose María ^a   Castillo, Jimena Del ^a   Carrillo, Angel ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Acute renal failure; Continuous renal replacement therapy; Critically ill children; Hypophosphatemia; Phosphate

Indexed keywords

ADRENALIN; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; FUROSEMIDE; INSULIN; ISOPRENALINE; MILRINONE; NORADRENALIN; SODIUM DIHYDROGEN PHOSPHATE; VASOACTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DIALYSATE; HUMAN; HYPOPHOSPHATEMIA; INFANT; MAJOR CLINICAL STUDY; MORBIDITY; NEWBORN; PARENTERAL NUTRITION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; RISK FACTOR; SUPPLEMENTATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HUMANS; HYPOPHOSPHATEMIA; INCIDENCE; PARENTERAL NUTRITION; PHOSPHATES; PROSPECTIVE STUDIES; RENAL REPLACEMENT THERAPY; RISK FACTORS; SPAIN; TREATMENT OUTCOME;

EID: 58349105341     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.570     Document Type: Article

References (15)

1. Charron T, Bernard F, Skrobik Y et al. Intravenous phosphate in the intensive care unit: more aggressive repletion regimens for moderate and severe hypophosphatemia. Intensive Care Med 2003; 29: 1273-1278.
2. Bugg NC, Jones JA. Hypophosphatemia. Pathophysiology, effects and management on the intensive care unit. Anaesthesia 1998; 53: 895-902.
3. Troyanov S, Geadah D, Ghannoum M et al. Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy. Intensive Care Med 2004; 30: 1662-1665.
4. Bellomo R, Ronco C. Continuous renal replacement therapy in the intensive care unit. Intensive Care Med 1999; 25: 781-789.
5. Tan HK, Bellomo R, M'Pis DA et al. Phosphatemic control during acute renal failure: intermittent hemodialysis versus continuous hemodiafiltration. Int J Artif Organs 2001; 24: 186-191.
6. Morimatsu H, Uchino S, Bellomo R et al. Continuous veno-venous hemodiafiltration or hemofiltration: impact on calcium, phosphate and magnesium concentrations. Int J Artif Organs 2002; 25: 512-519.
7. Ratanarat R, Brendolan A, Volker G et al. Phosphate kinetics during different dialysis modalities. Blood Purif 2005; 23: 83-90.
8. Ruiz P, López-Herce J, Martínez M et al. Alteraciones metabólicas en niños criticamente enfermos. An Esp Pediatr 1999; 51: 143-148.
9. The VA/NIH Acute Renal failure Trial Network Palevsky PM, Zhang JH, O'Connor TZ et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359: 7-20.
10. Dorval M, Pichette V, Cardinal J et al. The use of an ethanol- and phosphate-enriched dialysate to maintain stable serum ethanol levels during hemodialysis for methanol intoxication. Nephrol Dial Transplant 1999; 14: 1774-1777.
11. Chow MT, Lin HJ, Mitra EA et al. Hemodialysis-induced hypophosphatemia in a normophosphatemic patient dialyzed for ethylene glycol poisoning: treatment with phosphorus-enriched hemodialysis. Artif Organs 1998; 22: 905-907.
12. Gomez P, Coca C, Vargas C et al. Normal reference-intervals for 20 biochemical variables in healthy infants, children, and adolescents. Clin Chem 1984; 30: 407-412.
13. Lockitch G, Halstead AC, Albersheim S et al. Age- and sex-specific pediatric reference intervals for biochemistry analytes as measured with the Ektachem-700 analyzer. Clin Chem 1988; 34: 1622-1625.
14. Owen GM, Garry P, Fomon SJ. Concentrations of calcium and inorganic phosphorus in serum of normal infants receiving various feedings. Pediatrics 1963; 31: 495-498.
15. Greenberg BG, Winters RW, Graham JB. The normal range of serum inorganic phosphorus and its utility as a discriminant in the diagnosis of congenital hypophosphatemia. J Clin Endocrinol Metab 1960; 20: 364-379.